Hypertension is the most important single modifiable risk factor of stroke. The purpose of this study was to investigate the distribution patterns of risk factors of stroke and 10-year probability of stroke in hypertensive patients visiting community-based hospitals. A total of 1088 hypertensive patients who visited 61 communitybased hospitals nationwide were enrolled. Risk factors of stroke were evaluated using a series of laboratory tests and physical examinations, and the 10-year probability of stroke was determined by applying the Framingham stroke risk equation. The proportion of patients who have uncontrolled hypertension despite the use of antihypertensives was 63.3% (59.6% women, 68.7% men; P ¼ 0.006). The average 10-year probability of stroke in hypertensive patients was 16.05% (14.68% women, 17.99% men; Po0.001). The 10-year probability of stroke in patients with hypertension gradually increased in proportion to age. In patients treated with antihypertensives, 10-year probability of stroke gradually increased in proportion to blood pressure. The 10-year risk of stroke in hypertensive patients was approximately 4.6 times higher than that of stroke in the general population. In conclusion, as the 10-year risk of stroke in hypertensive patients was approximately 4.6 times higher than that of stroke in the general population, more aggressive interventions are needed to reduce blood pressure and stroke risk in hypertensive patients.
Introduction
Hypertension (HTN) is one of the most common chronic diseases in adults. Major complications of HTN include ischaemic heart diseases, stroke, heart failure, renal failure, aortic and peripheral arterial diseases. Stroke is the leading cause of death and disability among individuals older than 65 years in Korea. Among the total number of deaths, 13.9% is attributable to stroke-related deaths, and the annual medical cost for stroke accounted for more than 10% of total medical expenditure in Korea. 1, 2 In addition, stroke is becoming the major cause of death and behavioural disorder because of the rapid increase of senile population with the elongation of life expectancy. 3 Although there are various causes that induce stroke, 'HTN' and 'ageing' have been known to be the most common risk factors of stroke worldwide. 4, 5 Ageing is an irreversible factor but HTN is controllable. There was a report that an appropriate treatment for HTN was able to reduce the risk of stroke by 40% and the risk of acute myocardial infarction by 15%. 6 According to the related research, every increase of systolic blood pressure (SBP) and diastolic blood pressure (DBP), 20/10 mm Hg from 115/75 mm Hg, doubles the risk of stroke. 6 Framingham study in the United States, a reliable prospective epidemiology study on chronic diseases from 1948, elucidated that the risk factors of stroke included age, SBP, use of antihypertensives, diabetes, smoking, cardiovascular diseases (CVDs), atrial fibrillation and left ventricular hypertrophy (LVH). [7] [8] [9] In Korea, there was a report that the average 10-year probability of stroke in the general population was 3.52% for men and 3.66% for women. 10 Wolf et al. 7 showed that for each 10 mm Hg increase in SBP, the risk of stroke increased by 91% for men and 68% for women. However, to the best of our knowledge, there were rare epidemiologic reports about the probability of stroke in Korean hypertensive patients. Therefore, we planned to evaluate the 10-year probability of stroke in hypertensive patients visiting communitybased hospitals using Framingham risk score. 7 In addition, compared with the earlier study performed in the general population, 10 we intended to acknowledge the importance of treatment for HTN.
Materials and methods

Study population
This study is a multicentre study constituting 61 community-based hospitals in Korea. Study population was 1215 patients with HTN, 55-84 years of age, who visited 61 community-based hospitals. Among these, 127 patients were excluded because they had a previous history of stroke. Consequently, 1088 patients (449 men, 639 women) were enrolled for the study.
Laboratory and lifestyle factor measurement Blood pressure was measured in the right arm, using an appropriately sized cuff and a standard mercury sphygmomanometre, after the patients had been seated for at least 15 min, with the patients' feet on the floor and arm supported at heart level. Fasting blood samples were obtained in the morning after at least 8 h of fasting. Plasma glucose, total cholesterol, triglyceride, high-density lipoprotein cholesterol and low-density lipoprotein cholesterol were measured. Risk factors of stroke were age, diabetes, smoking, medical history of CVD, atrial fibrillation, LVH, hyperlipidaemia, alcohol intake, physical exercise, obesity and family history of stroke. Antihypertensives that the patient is currently receiving were classified as follows: angiotensinconverting enzyme inhibitor, angiotensin receptor blocker (ARB), calcium channel blocker, b-blocker, diuretics and others. The questionnaire required patients to estimate their alcohol intake, smoking history and amount of physical exercise.
Estimation of 10-year probability of stroke The 10-year probability of stroke was estimated using Framingham risk score 7 . The variables used for Framingham risk score were age, SBP, antihypertensive therapy, diabetes mellitus, smoking, CVD, atrial fibrillation and LVH. 14 was used to identify LVH. Cardiovascular disease was defined as coronary artery disease or congestive heart failure. Coronary artery disease was defined as any hospitalization for acute myocardial infarction or angina, and congestive heart failure was defined as any hospitalization for congestive heart failure. If stroke was developed in their first-line relative, patients were considered as having stroke family history. Hyperlipidaemia was defined as follows: patients receiving lipidlowering agents after diagnosis of hyperlipidaemia or whose total cholesterol is 240 mg per 100 ml.
Study definitions
We considered those patients who have the habit of drinking more than two glasses of Soju (Korean gin) a day in average for more than four times a week as drinkers. The patients answered to a question regarding physical activity: do you exercise regularly? The answer was divided into 'yes' or 'no'.
Statistical analysis
Statistical analysis was performed using the SPSS 10.0 software package (SPSS Inc., Chicago, IL, USA). Continuous variables were expressed as means ± s.d. and categorical variables were reported as number (%). Continuous variables were compared using Student's t-test or one-way analysis of variance. When we used one-way analysis of variance, post hoc multiple comparisons were performed using Duncan (D) multiple comparison test. Non-parametrical analysis for one-way analysis of variance was performed using Kruskal-Wallis analysis. Categorical variables were compared using a w 2 test or Fisher's exact test. Po0.05 was considered statistically significant.
Results
Baseline characteristics and risk factors
The baseline characteristics and risk factors of our patients are summarized in Table 1 . The patients comprised 449 men and 639 women. The mean age of patients was 67.66±4.95 years. The average SBP was 154±17 mm Hg and the average DBP was 92 ± 12 mm Hg. The prevalence of patients who took antihypertensives was 82.6% (83.2% women, 81.7% men; P ¼ 0.515). The prevalence of diabetes mellitus was 16% (17.2% women, 14.7% men; P ¼ 0.593) and the prevalence of cigarette smoking was 21.5% (22.1% women, 20.7% men; Po0.001). The prevalence of CVD was 13.6% (13.6% women, 13.6% men; P ¼ 0.989) and the prevalence of atrial fibrillation was 4.0% (4.2% women, 3.6% men; P ¼ 0.581). The prevalence of LVH was 15.3% (14.6% women, 16.5% men; P ¼ 0.385). Women were older than men. In women, heart rate was higher compared with that of men and the number of patients who took lipid-lowering agents was more compared with that of men. On the contrary, in men, the prevalences of smoking, drinking, physical exercise and the number of patients who took antiplatelet agents were higher compared with those of women. The proportion of patients who have uncontrolled HTN despite use of antihypertensives was 63.3% (59.6% women, 68.7% men; P ¼ 0.006; Figure 1 ).
Ten-year probability of stroke The average 10-year probability of stroke was 16.05% (14.68% women, 17.99% men) ( Figure 2 ). As expected, the 10-year probability of stroke in patients with HTN gradually increased in proportion to age (Table 2 ). Figure 3 shows the average 10-year probability of stroke between men and women Probability of stroke in Korean hypertensive patients CG Park and CU Choi according to ages. In the age group 474 years, there was no difference in the 10-year probability of stroke between men and women. However, in other age groups, men's 10-year probability of stroke was higher than women's. Table 3 shows the average 10-year probability of stroke according to blood pressure in patients treated with antihypertensives. In patients treated with antihypertensives, 10-year probability of stroke gradually increased in proportion to blood pressure. According to HTN stage, the difference in average 10-year probability of stroke between men and women is shown in Figure 4 . In HTN stage 2, 10-year probability of stroke was higher in men compared with that of women, but in other HTN stages, it was not different between men and women. Figure 3 The difference in average 10-year probability of stroke between men and women according to age. 
Discussion
This study is the first report that is designed to predict the 10-year probability of stroke among Korean hypertensive patients visiting communitybased hospitals using Framingham risk score.
The main result of this study was that the average 10-year probability of stroke in hypertensive patients visiting community-based hospitals was 16.05% (14.68% women, 17.99% men). When compared with the results of the previous study, 10 10-year risk of stroke in hypertensive patients visiting community-based hospitals was approximately 4.6 times higher than that of stroke in the general population. This result was driven by the fact that among hypertensive patients, 17.6% did not take antihypertensives (Table 1) and therefore blood pressure was not well controlled. Another possible cause of this result was that among patients treated with antihypertensives, the proportion of uncontrolled HTN was 63.3% (Figure 1 ). In addition, even in patients treated with antihypertensives, 10-year probability of stroke gradually increased in proportion to blood pressure (Table 3) . These findings give us a lesson that more strict control of HTN could be an important intervention for prevention of stroke.
In HTN stage 2, 10-year probability of stroke was high in men compared with that of women, but in other HTN stages, it was not different between men and women (Figure 4) . In HTN stage 2, men were older than women but in other HTN stages, this difference was not observed. In addition, distribution of other risk factors between men and women was not different according to stage of HTN (data are not shown). Therefore, we thought that the differences in 10-year probability of stroke between men and women in HTN stage 2 were driven by the distribution of age.
Ten-year probability of stroke in patients with HTN gradually increased in proportion to age (Table 2 ), but the distribution of 10-year probability of stroke between men and women varied according to age. In the age group 474 years, there was no difference in 10-year probability of stroke between men and women, but in other age groups, men's 10-year probability of stroke was higher than women's ( Figure 3 ). In the age group 474 years, distribution of other risk factors between men and women was not different, but in other age groups, history of smoking was higher in men compared with that of women (data are not shown). Therefore, we also thought that the difference in 10-year probability of stroke between men and women in the age group 60-69 years was driven by the distribution of history of smoking.
The prevalence of diabetes mellitus in hypertensive patients was 21.5% (22.1% women, 20.7% men; Table 1 ). This prevalence was higher than that of a previous study (Korean National Health and Nutrition Examination Survey 15 ). The Korean National Health and Nutrition Examination Survey showed that in the general Korean population, the prevalence of diabetes mellitus was 9.1% (7.9% women, 10.2% men). As our enrolled participants were older and high-risk patients, this difference between two studies could come about. The prevalence of hyperlipidaemia in hypertensive patients was 17.0% (18.8% women, 14.5% men; Table 1 ). This prevalence was lower than that of a previous study (Korean National Health and Nutrition Examination Survey 15 ). The Korean National Health and Nutrition Examination Survey 15 showed that in the general Korean population, the prevalence of dyslipidaemia was 48.3% (38.2% women, 58.9% men). As our enrolled participants were older and high-risk patients and had taken anti-lipid-lowering agents already, this difference between two studies could come about.
In Korean hypertensive patients visiting community-based hospitals, the prescription of ARB was top ranked by 77.0% among the antihypertensives and was higher than that of calcium channel blocker by 50.0%. Many physicians working at communitybased hospitals prefer ARB to other antihypertensives due to the high compliance and few side effects. In addition, many clinical data about the effect of ARB on the prevention of stroke and CVDs are being published recently. 16 The prescription of angiotensin-converting enzyme inhibitor was only 8.9%. This low frequency was driven by the side effects of angiotensin-converting enzyme inhibitor such as cough and the switch into ABR. Among Korean hypertensive patients visiting communitybased hospitals, 81.3% took more than two antihypertensives (Table 4 ). This frequency was approximately 2.2 times higher than that in the United States (35.8%, 1999-2002). 17 In our study, the proportion of antihypertensives in hypertensive patients visiting community-based hospitals was 82.6% (Table 1 ) and the proportion of patients who have uncontrolled HTN among patients treated with antihypertensives was 63.3% ( Figure 1 ). These results were high compared with those of Korean National Health and Nutrition Examination Survey. 15 As the study population was derived from a selected group of patients who were visiting community-based hospitals for presumably suspected or established cardiac diseases, the proportion of antihypertensives and the proportion of patients who have uncontrolled HTN could be high.
This study has some limitations. First, the study population is not representative of real HTN population in Korea but derived from a selected group of patients who were visiting communitybased hospitals for presumably suspected or established cardiac diseases. Although it is appropriate to do the study collectively with cooperated participation of community-based hospitals, public health centres and general hospitals, our study was carried out only for community-based hospitals. Therefore, the cardiovascular risk factors are over-represented and it cannot be denied that enrolled patients were hypertensive patients with a higher risk than real HTN population. Second, this study was a simple cross-section study and we had no information about the practical stroke event. Therefore, we did not compare 10-year probability of stroke with real stroke incidence. If a well-controlled large prospective study could be carried out for hypertensive patients visiting community-based hospitals, we could analyse the relation between the 10-year probability of stroke and real stroke incidence. Third, we did not compare the 10-year probability of stroke between hypertensive patients and the general population, but compared indirectly the results from the earlier study. 10 Fourth, we measured smoking, physical activity and alcohol consumption with a single, self-reported questionnaire. Therefore, non-differential misclassification was possible.
In conclusion, the average 10-year probability of stroke in hypertensive patients visiting communitybased hospitals was 16.05% and this level was approximately 4.6 times higher than that of stroke in the general population. In addition, the probability of stroke was increased with severity of blood pressure in patients treated with antihypertensives. Therefore, we suggest that more strict control of HTN could be an important intervention for prevention of stroke.
